Literature DB >> 33580211

Risk of kidney disease after living kidney donation.

Arthur J Matas1, Andrew D Rule2.   

Abstract

Entities:  

Year:  2021        PMID: 33580211      PMCID: PMC8292201          DOI: 10.1038/s41581-021-00407-5

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

Authors:  Allan B Massie; Abimereki D Muzaale; Xun Luo; Eric K H Chow; Jayme E Locke; Anh Q Nguyen; Macey L Henderson; Jon J Snyder; Dorry L Segev
Journal:  J Am Soc Nephrol       Date:  2017-04-27       Impact factor: 10.121

2.  "You can't get there from here": Critical obstacles to current estimates of the ESRD risks of young living kidney donors.

Authors:  Robert W Steiner
Journal:  Am J Transplant       Date:  2018-10-03       Impact factor: 8.086

3.  Risk of ESRD in prior living kidney donors.

Authors:  Jennifer L Wainright; Amanda M Robinson; Amber R Wilk; David K Klassen; Wida S Cherikh; Darren E Stewart
Journal:  Am J Transplant       Date:  2018-03-08       Impact factor: 8.086

4.  A prospective controlled study of metabolic and physiologic effects of kidney donation suggests that donors retain stable kidney function over the first nine years.

Authors:  Bertram L Kasiske; Tracy L Anderson-Haag; Daniel A Duprez; Roberto S Kalil; Paul L Kimmel; Todd E Pesavento; Jon J Snyder; Matthew R Weir
Journal:  Kidney Int       Date:  2020-02-03       Impact factor: 10.612

5.  A Case-Based Analysis of Whether Living Related Donors Listed for Transplant Share ESRD Causes with Their Recipients.

Authors:  Arthur J Matas; Rebecca E Hays; Hassan N Ibrahim
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-01       Impact factor: 8.237

6.  Long-term risks for kidney donors.

Authors:  Geir Mjøen; Stein Hallan; Anders Hartmann; Aksel Foss; Karsten Midtvedt; Ole Øyen; Anna Reisæter; Per Pfeffer; Trond Jenssen; Torbjørn Leivestad; Pål-Dag Line; Magnus Øvrehus; Dag Olav Dale; Hege Pihlstrøm; Ingar Holme; Friedo W Dekker; Hallvard Holdaas
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

7.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

8.  Risk of end-stage renal disease following live kidney donation.

Authors:  Abimereki D Muzaale; Allan B Massie; Mei-Cheng Wang; Robert A Montgomery; Maureen A McBride; Jennifer L Wainright; Dorry L Segev
Journal:  JAMA       Date:  2014-02-12       Impact factor: 56.272

9.  How do living kidney donors develop end-stage renal disease?

Authors:  R Kido; Y Shibagaki; K Iwadoh; I Nakajima; S Fuchinoue; T Fujita; S Teraoka
Journal:  Am J Transplant       Date:  2009-08-14       Impact factor: 8.086

10.  GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.

Authors:  Arthur J Matas; David M Vock; Hassan N Ibrahim
Journal:  Am J Transplant       Date:  2017-12-01       Impact factor: 8.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.